Association of tumor mutational burden with efficacy of Pembrolizumab±Chemotherapy as first-line therapy for gastric cancer in the phase III KEYNOTE-062 study
Lee, K. -., Van Cutsem, E., Bang, Y. -., Fuchs, C. S., Kudaba, I., Garrido, M., Tabernero, J., . . … Read More
